Copenhagen - Free Realtime Quote DKK

Orphazyme A/S (ORPHA.CO)

Compare
1,140.00 -103.40 (-8.32%)
As of 4:44 PM GMT+2. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.
NameTitlePayExercisedYear Born
Mr. Jakob F?rch Bendtsen CEO & Director -- -- 1978

Orphazyme A/S

Visionhouse
Lysk?r 8A
Herlev, 2730
Denmark
https://www.orphazyme.com
Sector:?
Healthcare
Industry:?
Biotechnology
Full Time Employees:?
1

Description

Orphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark.

Corporate Governance

Orphazyme A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 18, 2024 at 10:59 AM UTC

Orphazyme A/S Earnings Date

Recent Events

Related Tickers